Chimerix, Inc (CMRX) Covered Calls

Chimerix, Inc covered calls Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157.

You can sell covered calls on Chimerix, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CMRX (prices last updated Fri 12:55 PM ET):

Chimerix, Inc (CMRX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.91 -0.01 1.90 1.91 804K - 0.1B
Covered Calls For Chimerix, Inc (CMRX)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 2.5 0.05 1.86 2.7% 44.8%
Apr 18 2.5 0.00 1.91 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Chimerix, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel, oral antiviral therapeutics designed to address unmet medical need. Its proprietary lipid technology to unlock the potential of some of the most broad-spectrum antivirals by enhancing their antiviral activity and safety profiles in convenient, orally administered dosing regiments. The company has two nucleotide compounds in clinical development that utilize their proprietary lipid technology. Brincidofovir and CMX157. Chimerix was founded by George R. Painter and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.